Education and Work Experience: He enrolled at Sun Yat-sen University (formerly Zhongshan Medical College) in 1989 and graduated in 1996 with a master’s degree under the seven-year program. His master’s thesis focused on heart rate variability in patients with hypertension. He obtained his doctoral degree in Cardiology in 2004, with his doctoral dissertation on leptin in heart failure. He won the first prize in the English Group of the First Young and Middle-aged Teacher Teaching Competition of Sun Yat-sen University in 2006. In 2008, he received further training in cardiovascular ultrasound at the Prince of Wales Hospital in Hong Kong. He conducted postdoctoral research at UT Southwestern Medical Center from 2011 to 2013, focusing on stem cell therapy for cardiovascular and cerebrovascular diseases. His postdoctoral project covered the development of small-molecule compounds promoting the regeneration of cardiomyocytes and brain cells, as well as the protective effect of G protein-coupled receptor (GPR68), a novel therapeutic target for coronary heart disease, on myocardial ischemia and hypoxia.

Research Interests: ① Pharmacotherapy for various cardiovascular diseases, especially individualized medication; ② Rehabilitation and secondary prevention of coronary heart disease, heart failure and hypertension.

Medical Expertise: Diagnosis and treatment of hypertension, coronary heart disease, heart failure, arrhythmia, valvular heart disease and cardiomyopathy. He specializes in: ① Pharmacotherapy for cardiovascular diseases, including hypertension, coronary heart disease, heart failure, hyperlipidemia, valvular heart disease, cardiomyopathy and metabolic syndrome; ② Comprehensive rehabilitation guidance for patients with cardiovascular diseases and post-cardiac surgery patients, covering lifestyle modification, cardiac functional rehabilitation, mental health recovery, evidence-based standardized medication, quality-of-life assessment and vocational rehabilitation; ③ Secondary prevention of coronary heart disease (recurrence prevention), and multi-dimensional management including medication, nutrition, exercise, sleep and psychology for hypertensive patients based on risk stratification; ④ Primary prevention for populations at risk of cardiovascular diseases (onset prevention).